Aptevo Therapeutics (APVO) Q1 2025 Earnings

14FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-21.09
-14.62
-8.14
-1.67

Details

Expected EPS
-7.75
Actual EPS
-8.94
Surprise EPS
-1.19
Surprise Percent
+15.35%

Description

Aptevo Therapeutics (APVO) has reported earnings of -8.94 per share for Q1 2025.

0 Comments

Share your thoughts